Home › Funds › RA CAPITAL MANAGEMENT, L.P. › ARTV
RA CAPITAL MANAGEMENT, L.P. position in ARTV
ARTIVA BIOTHERAPEUTICS INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 23,792,226 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$220.2M, representing 2.27% of its reported portfolio and ranking #9 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed ARTV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s ARTV position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in ARTV in Q3 2024 at 9,853,302 shares (US$152.2M). The position peaked in Q3 2026 at 23,792,226 shares, worth US$220.2M. Across 9 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 23,792,226 shares valued at US$220.2M — an increase of 5,836,584 shares quarter over quarter.. Notable position changes include a 82% increase in Q2 2026 (shares fell 27% over the following quarter), a 33% increase in Q3 2026 (shares fell 44% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 9.85M | $152.23M | New |
| Q4 2024 | 9.85M | $99.32M | Hold |
| Q1 2025 | 9.85M | $29.56M | Hold |
| Q2 2025 | 9.85M | $14.88M | Hold |
| Q3 2025 | 9.85M | $28.28M | Hold |
| Q4 2025 | 9.85M | $42.27M | Hold |
| Q1 2026 | 9.85M | $63.46M | Hold |
| Q2 2026 | 17.96M | $174.17M | Add |
| Q3 2026 | 23.79M | $220.20M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARTV and 13F data
ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 87 other funds we track also report a position in ARTV — the largest reported positions include 5AM Venture Management, LLC (US$139.1M), Deep Track Capital, LP (US$73.6M), Blue Owl Capital Holdings LP (US$63.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- 5AM Venture Management, LLC 9.68M sh · $139.10M · Q3 2026
- Deep Track Capital, LP 4.41M sh · $73.62M · Q3 2026
- Blue Owl Capital Holdings LP 4.13M sh · $63.84M · Q3 2026
- Foresite Capital Management V, LLC 3.56M sh · $59.50M · Q3 2026
- Foresite Capital Management VI LLC 2.20M sh · $36.80M · Q3 2026
- Cormorant Asset Management, LP 1.82M sh · $30.32M · Q3 2026
- ORBIMED ADVISORS LLC 1.68M sh · $27.98M · Q3 2026
- Venrock Adviser, LLC 2.04M sh · $14.55M · Q3 2026
- Sanofi 672.78K sh · $11.24M · Q3 2026
- Caligan Partners LP 1.48M sh · $10.55M · Q3 2026
- Samsara BioCapital, LLC 954.86K sh · $6.80M · Q3 2026
- Saturn V Capital Management LP 300.36K sh · $5.02M · Q3 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held ARTV?
RA CAPITAL MANAGEMENT, L.P. has disclosed ARTV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in ARTV?
As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 23.79M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $220.20M, representing 2.27% of its reported portfolio and ranking #9.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling ARTV?
In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. increased its position in ARTV. The position peaked in Q3 2026 at 23.79M shares.
Which other funds hold ARTV?
Other major institutional holders of ARTV include 5AM Venture Management, LLC, Deep Track Capital, LP, Blue Owl Capital Holdings LP, among 87 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.